pharmazz

Hypovolemic Shock

Gulati, A., Goyal, A. O., Lavhale, M. S., Gulati, S., and M., S. (2016) Human Pharmacokinetics of Centhaquin Citrate, a Novel Resuscitative Agent. Circulation, 134:A16607

Read more publications

Alzheimer's Disease

Briyal, S., C. Nguyen, M. Leonard, and A. Gulati. Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer’s disease. Neuroscience 301 (2015): 1-11

Read more publications

Post Operative Pain

Leonard, M. G., Jung, S., Andurkar, S. V., and Gulati, A. (2014) Centhaquin Produces Dose-dependent Antinociception in a Rat Model of Post-operative Pain. Clin Pharmacol in Drug Develop 3, 52-53

Read more publications

Ischemic Stroke

Leonard, M. G., and Gulati, A. (2013) Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats. Brain Res 1528, 28-41

Read more publications

Cardiac Arrest

Papalexopoulou, K., Chalkias, A., Pliatsika, P., Papalois, A., Papapanagiotou, P., Papadopoulos, G., Arnaoutoglou, E., Petrou, A., Gulati, A., and Xanthos, T. (2017) Centhaquin Effects in a Swine Model of Ventricular Fibrillation: Centhaquin and Cardiac Arrest. Heart Lung Circ 26, 856-863

Read more publications

Spinal Cord Injury

Leonard, M. G., Prazad, P., Puppala, B., and Gulati, A. (2015) Selective Endothelin-B Receptor Stimulation Increases Vascular Endothelial Growth Factor in the Rat Brain during Postnatal Development. Drug Res (Stuttg) 65, 607-613

Read more publications

Diabetic Ketoacidosis

Gulati, A.,   Lavhale, M.,   and   Havalad, S. (2013) BQ123,   An ETA receptor antagonist,   in the treatment of   Diabetic   Ketoacidosis.   Crit   Care   Med 41      

Read more publications

Tumor Diagnosis

Rai, A., and Gulati, A. (2003) Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor. Cancer Chemother Pharmacol 51, 21-28

Read more publications